Effect of fezolinetant on moderate-to-severe vasomotor symptoms in subgroups based on hormone therapy history: pooled data from two randomized phase 3 studies

被引：0

作者：

Santoro, Nanette ^{[1
]}

Neal-Perry, Genevieve ^{[2
]}

Stute, Petra ^{[3
]}

Blogg, Martin ^{[4
]}

Mancuso, Shayna ^{[5
]}

Morga, Antonia ^{[4
]}

Ottery, Faith D. ^{[5
]}

Siddiqui, Emad ^{[4
]}

机构：

[1] Univ Colorado, Sch Med, Aurora, CO USA

[2] UNC Sch Med, Chapel Hill, NC USA

[3] Inselspital Bern, Bern, Switzerland

[4] Astellas Pharma Europe Ltd, Addlestone, Surrey, England

[5] Astellas Pharma Global Dev Inc, Northbrook, IL USA

来源：

MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY | 2023年 / 30卷 / 12期

关键词：

D O I：

暂无

中图分类号：

R71 [妇产科学];

学科分类号：

100211 ;

摘要：

S-8

引用

页码：1259 / 1259

页数：1

共 50 条

[41] The Effect Of Lebrikizumab Therapy On Key Type 2 Biomarkers In Moderate-To-Severe, Uncontrolled Asthma Patients: A Pooled Analysis From Phase 2 Trials [J].

Hanania, N. A. ;

Korenblat, P. ;

Corren, J. ;

Olsson, J. ;

Kamath, N. ;

Gray, S. ;

Martin, N. ;

Holweg, C. T. J. ;

Matthews, J. G. ;

Scheerens, H. ;

Limb, S. L. ;

Korom, S. .

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193

[42] Bimekizumab efficacy for moderate to severe plaque psoriasis across patient subgroups: Pooled results from 3 multicenter, randomized, double-blinded phase 3 trials [J].

Strober, Bruce ;

Warren, Richard B. ;

Foley, Peter ;

Gooderham, Melinda ;

Thaci, Diamant ;

Cullen, Eva ;

Cioffi, Christopher ;

Peterson, Luke ;

Madden, Cynthia ;

Armstrong, April .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (03) :AB76-AB76

[43] Long-term safety of tildrakizumab in patients with moderate-to-severe psoriasis: pooled analysis through 148 weeks from two phase 3 trials [J].

Reich, K. ;

Thaci, D. ;

Pau-Charles, I. ;

Igarashi, A. ;

Ohtsuki, M. ;

Lebwohl, M. ;

Cantrell, W. ;

Rozzo, S. ;

Blauvelt, A. ;

Iversen, L. .

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2019, 33 :47-48

[44] Secukinumab shows efficacy regardless of baseline disease severity in subjects with moderate-to-severe plaque psoriasis: a pooled analysis from four phase 3 studies [J].

Spelman, L. J. ;

Blauvelt, A. ;

Loffler, J. ;

Fox, T. ;

Papavassilis, C. .

AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2015, 56 :73-73

[45] Effect of continuous positive airway pressure in very elderly with moderate-to-severe obstructive sleep apnea pooled results from two multicenter randomized controlled trials [J].

Martinez-Garcia, M. A. ;

Oscullo, G. ;

Ponce, S. ;

Pastor, E. ;

Orosa, B. ;

Catalan, P. ;

Martinez, A. ;

Hernandez, L. ;

Muriel, A. ;

Chiner, E. ;

Vigil, L. ;

Carmona, C. ;

Mayos, M. ;

Garcia-Ortega, A. ;

Gomez-Olivas, J. D. ;

Beauperthuy, T. ;

Bekki, A. ;

Gozal, D. .

SLEEP MEDICINE, 2022, 89 :71-77

[46] Dupilumab Improves General Health-Related Quality-of-Life in Patients with Moderate-to-Severe Atopic Dermatitis: Pooled Results from Two Randomized, Controlled Phase 3 Clinical Trials [J].

Eric L. Simpson .

Dermatology and Therapy, 2017, 7 :243-248

[47] Dupilumab Improves General Health-Related Quality-of-Life in Patients with Moderate-to-Severe Atopic Dermatitis: Pooled Results from Two Randomized, Controlled Phase 3 Clinical Trials [J].

Simpson, Eric L. .

DERMATOLOGY AND THERAPY, 2017, 7 (02) :243-248

[48] A Phase 3, randomized, placebo-controlled, 12-week, double-blind study, plus a non-controlled extension treatment period, to assess efficacy and safety of fezolinetant, a neurokin-3 receptor antagonist, in women with moderate-to-severe vasomotor symptoms associated with menopause [J].

Johnson, Kimball ;

Lademacher, Christopher ;

Nappi, Rossella E. ;

Neal-Perry, Genevieve ;

Shapiro, Marla ;

Stute, Petra ;

Thurston, Rebecca C. ;

Wolfman, Wendy ;

English, Marci ;

Franklin, Catherine ;

Lee, Misun ;

Santoro, Nanette .

MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2021, 28 (12) :1450-1450

[49] Efficacy of tofacitinib for the treatment of nail psoriasis: Two 52-week, randomized, controlled phase 3 studies in patients with moderate-to-severe plaque psoriasis [J].

Merola, Joseph F. ;

Elewski, Boni ;

Tatulych, Svitlana ;

Lan, Shuping ;

Tallman, Anna ;

Kaur, Mandeep .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2017, 77 (01) :79-+

[50] Improvements in health-related quality of life and symptoms of depression with tofacitinib: Results from two randomized phase 3 studies in patients with moderate to severe psoriasis [J].

Thaci, Diamant ;

Griffiths, Christopher E. M. ;

Bundy, Christine ;

Korman, Neil J. ;

Lan, Shuping ;

Robertson, Deborah ;

Tatulych, Svitlana ;

Tallman, Anna ;

Kaur, Mandeep ;

Mamolo, Carla .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2016, 74 (05) :AB255-AB255

← 1 2 3 4 5 →